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Abstract
Background: No systematic review has previously been carried out on randomised controlled trials (RCTs) of
veterinary homeopathy in which the control group was an intervention other than placebo (OTP). For eligible
peer-reviewed RCTs, the objectives of this study were to assess the risk of bias (RoB) and to quantify the effect
size of homeopathic intervention compared with an active comparator or with no treatment.
Methods: Our systematic review approach complied fully with the PRISMA 2009 Checklist. Cochrane methods
were applied to assess RoB and to derive effect size using standard meta-analysis methods. Based on a thorough
and systematic literature search, the following key attributes of the published research were distinguished:
individualised homeopathy (n = 1 RCT)/non-individualised homeopathy (n = 19); treatment (n = 14)/prophylaxis
(n = 6); active controls (n = 18)/untreated controls (n = 2). The trials were highly diverse, representing 12 different
medical conditions in 6 different species.
Results: No trial had sufficiently low RoB to be judged as reliable evidence: 16 of the 20 RCTs had high RoB; the
remaining four had uncertain RoB in several domains of assessment. For three trials with uncertain RoB and
without overt vested interest, it was inconclusive whether homeopathy combined with conventional intervention
was more or was less effective than conventional intervention alone for modulation of immune response in
calves, or in the prophylaxis of cattle tick or of diarrhoea in piglets.
Conclusion: Due to the poor reliability of their data, OTP-controlled trials do not currently provide useful insight
into the effectiveness of homeopathy in animals.
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Background
Our group’s systematic analysis of the published litera-
ture of randomised controlled trials (RCTs) in veterinary
homeopathy identified 38 peer-reviewed papers that we
regarded as potentially eligible for detailed review [1]. As
emphasised in that article, no systematic review of this
research evidence had ever previously been carried out.
We have recently reported our review findings for 18
placebo-controlled trials of veterinary homeopathy [2, 3],
in which there was indecisive evidence whether the use of
homeopathy in animals is distinguishable from placebos.
The present paper reports our results from a similarly de-
tailed appraisal and analysis of the remaining papers, each
of which reported an RCT where the control group was
an intervention other than placebo (OTP).
Our approach here reflects our original literature ana-
lysis [1] and so we continue to distinguish peer-reviewed
from non-peer-reviewed articles, individualised from
non-individualised homeopathy, and treatment from
prophylaxis. We thus report our findings from the ap-
praisal of peer-reviewed, OTP-controlled trials of veter-
inary homeopathy (individualised or non-individualised,
treatment or prophylaxis).
Our objective firstly was to assess the study quality
(risk of bias) of each eligible RCT [4], together with the
direction and statistical significance of treatment or
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prophylactic effect. For suitable groupings of RCTs (per
species-specific medical condition; per type of control
group), we aimed then to determine pooled summary
statistics by meta-analysis methods and to examine their
sensitivity to study quality. In both objectives, our em-
phasis was focused on trials that satisfied our criteria for
reliable evidence [2, 3].
Methods
Methods comply with the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) 2009
Checklist (see Additional file 1) [5]. They are compatible
with our previously published papers in this series of vet-
erinary reviews [1–3], and with our protocol-based sys-
tematic reviews and meta-analyses of homeopathy RCTs
in human medicine [6, 7].
Matters connected with study eligibility, research design
categories and the literature search strategy were described
in detail in our earlier paper [1]. Only brief descriptions
are therefore given here, with additional information that
is specific to the methods used for the present paper.
Identifying papers for full data extraction
Each of the following electronic databases was searched up
to and including March 2011 [1], with a follow-up search
of the same databases up to the end of 2013: AMED,
CINAHL, CENTRAL, Embase, HomVetCR, LILACS,
PubMed, Science Citation Index, Scopus. There were no
language restrictions. During the peer-review process for
the current paper, we became aware that relevant additional
literature might be contained in CAB Abstracts [8], which
we therefore searched up to and including May 2015, and
with the intention to update our review and analysis if sig-
nificant numbers of eligible RCTs were revealed.
In our original literature search [1], 20 records of trials
were identified as satisfying the key acceptance criteria for
the present systematic review: substantive report of clin-
ical treatment or prophylaxis trial for any medical condi-
tion or species in veterinary homeopathic medicine,
randomised, controlled by OTP, and published in a peer-
reviewed journal. One of us screened and categorised each
of these potentially relevant papers (plus those identified
in our follow-up search – see Results) to assess their eligi-
bility for full data extraction. The other independently ap-
praised these decisions; any differences of opinion were
resolved by consensus discussion.
Exclusion criteria prior to full data extraction
 Research using radionically prepared ‘homeopathic’
medicines.
 The tested intervention is homeopathy combined
with other (complementary or conventional)
medicine or therapy.
Data extraction and management
The authors of eligible RCT papers were not approached
for clarification on unclear or missing facets of their
methods or results [4], though original authors’ cross-
reference to their previously published study methods
were taken into account as appropriate [2]. For each of
two assessors working independently, relevant data were
extracted and then recorded using a standardised data
collection format (Microsoft Excel).
No paper reported more than one RCT. For a paper
reporting an RCT that involved >2 groups of subjects,
we typically pursued data extraction on only one pair of
groups: trials that included an OTP as well as a placebo
control group had been scrutinised previously [2, 3] and
were not reappraised for the current study. For studies
that comprised >1 homeopathy group, the total sample
size reflects the total numbers of subjects in the hom-
eopathy groups combined [9]. This was the approach in
all relevant cases, i.e.: where the same homeopathic
medicine was used, and with the same timing of admin-
istration but in different potency; where the same
homeopathic medicine and potency was used, but with
different timing of administration; where a different
homeopathic medicine was used.
Study appraisal
Assessment of risk of bias
Using the standard criteria defined by Cochrane [4], ex-
traction of information from each paper enabled us to
answer the question, ‘Is the study free from risk of bias?’:
‘Yes’; ‘Unclear’; ‘No’. The two assessors’ independent
judgments were mutually scrutinised and compared,
with discrepancies between them resolved by consensus
discussion. This approach applied to each of seven as-
sessment domains: I, the method used to generate the
random sequence; II, the method of allocation conceal-
ment used to implement the random sequence; IIIA, the
blinding of trial personnel, including animal owner as
appropriate; IIIB, the blinding of outcome assessors; IV,
whether all the randomised patients are accounted for in
the analysis; V, whether there is evidence of selective
outcome reporting; VI, whether there is evidence of
other bias, such as extreme data imbalance at baseline.
For domain IV, a trial was automatically regarded as no
better than ‘unclear’ if there was greater than 20 % partici-
pant attrition rate, irrespective of whether intention-to-
treat analysis had been carried out on the data. For domain
V, we based our judgment of reported outcomes on a com-
parison with the details given in the same paper’s Methods
section (original trial protocols have not been published in
veterinary homeopathy). For the purposes of the current
paper, we assessed domain V as ‘No’ (high risk of bias) if
the main outcome data were not extractable for meta-
analysis. The source of any research funding/sponsorship,
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or other vested interest such as personnel employment or
contract, was not taken into account for risk-of-bias assess-
ment (domain VI), but was reflected in the overarching as-
sessment of risk of bias for each RCT.
Assessment per trial for risk of bias
Using the Cochrane approach [4], each trial was designated
overall as follows: low risk of bias for all domains; uncertain
risk of bias for one or more domains, and no evident risk
of bias in any domain; high risk of bias for one or more do-
mains. A trial with overall low risk of bias comprised reli-
able evidence. For a trial that did not display high risk of
bias in any domain, we regarded its evidence as reliable if
the study was assessed as free of bias for each of domains I,
IIIA, IIIB and IV [2, 3].
Outcome assessment and reporting
Identification of ‘main outcome measure’ per trial
For the purposes of risk-of-bias assessment and for assess-
ment of treatment effect, we identified for each trial a sin-
gle ‘main outcome measure’ using a refinement of the
approaches adopted by Linde et al. [10] and by Shang et al.
[11]. The main outcome measure of each trial was based
on a hierarchical ranking order (consistent with the World
Health Organization’s [12] classification system for levels
of functioning linked to health condition), and as previ-
ously described [2]. This approach ensured that the most
clinically important outcome was selected per trial, and
also avoided the problem of outcome multiplicity [13].
Unless otherwise indicated, the single end-point (as
determined from the start of the intervention) associ-
ated with the designated ‘main outcome measure’ was
taken as the last follow-up at which data were re-
ported for that outcome [2].
Analysis of outcomes
Summary effect measures for ‘main outcome’
For each eligible trial, the effect size was taken as the
difference between the homeopathy group and the
control group at the designated end-point of the trial,
as follows [2]:
 For a dichotomous measure: odds ratio (OR), with
95 % confidence interval (CI);
 For a continuous measure: standardised mean
difference (SMD), with 95 % CI.
If the original paper did not provide adequate informa-
tion on the designated main outcome measure to enable
data extraction, that trial’s outcome was classified as ‘not
estimable’ and a further potentially estimable outcome
was not sought.
Under the separate group headings of individualised
homeopathy and non-individualised homeopathy, and
for the categories below in which there was >1 RCT of a
given study design that had extractable data, we aimed
to determine pooled summary statistics for:
 Disease-specific treatment effects per species;
 Disease-specific prophylactic effects per species.
All calculations and analyses were performed using
Review Manager 5.2 (Cochrane). Given our anticipation
of heterogeneous data for intervention effects, the
random-effects (rather than fixed-effects) model was
planned for all meta-analyses [14].
Reflecting study quality overall
Our main analyses used only the data extracted from tri-
als without evident high risk of bias. It was intended that
our primary conclusions would be based solely on trials
with reliable evidence and without overt vested interest
(not funded, directly or indirectly, by a homeopathic
pharmacy).
Direction of effect of treatment/prophylaxis per trial
Care was taken faithfully to represent the correct direction
of change per trial: e.g. an effect favouring homeopathic
intervention was higher rate of recovery but lower faecal
egg count. The arithmetic content of the OR, or the sign
of the SMD, was adjusted appropriately if so indicated.
We regarded each RCT as a superiority trial [15] un-
less the original paper stated explicitly in its Methods
section that the study was designed as an equivalence or
non-inferiority trial [16, 17], with corresponding power
calculation. For each of three study designs (and regarding
each design as a superiority trial), we adopted the fol-
lowing rationale for interpretation of the three possible
statistical findings:
Statistical finding (i): P ≤ 0.05: Direction of effect to-
ward homeopathy
a. Study design: active control. Homeopathy is more
effective than a conventional intervention;
b. Study design: [homeopathy plus active control] versus
active control (‘[A + B] versus B’). Homeopathy
combined with conventional intervention is more
effective than conventional intervention alone;
c. Study design: no-treatment control. Homeopathy is
more effective than no intervention.
Statistical finding (ii): P ≤ 0.05: Direction of effect to-
ward control
a. Study design: active control. Homeopathy is less
effective than a conventional intervention;
b. Study design: [homeopathy plus active control] versus
active control (‘[A + B] versus B’). Homeopathy
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combined with conventional intervention is less
effective than conventional intervention alone;
c. Study design: no-treatment control. Homeopathy is
ineffective.
Statistical finding (iii): P > 0.05: Direction of effect to-
ward either homeopathy or control
a. Study design: active control. Inconclusive whether
homeopathy is more or is less effective than a
conventional intervention [18, 19];
b. Study design: [homeopathy plus active control] versus
active control (‘[A + B] versus B’). Inconclusive
whether homeopathy combined with conventional
intervention is more or is less effective than
conventional intervention alone;
c. Study design: no-treatment control. Inconclusive




Additional file 2 illustrates the PRISMA flowchart,
which follows on from, and suitably updates [20], that
in our earlier paper [1]; our current focus is on OTP-
controlled trials only. Two OTP-controlled trials were
rejected from the current review due to their focus on
homeopathy combined with another intervention: A29,
Dreissman 2010; A30, Lepple 1984. A further two were
excluded due to their focus on neither treatment nor
prophylaxis: A33, Sharma 1987; A37, Trehan 1994.
Four additional eligible records were identified in our
follow-up search, and included in analysis. Our subse-
quent search of CAB Abstracts, conducted during peer
review of the current paper, revealed just one poten-
tially eligible trial [21], which we did not consider
further.
Table 1 details each of the 20 studies eligible for full
systematic review: (i) individualised homeopathy/treat-
ment (n = 1); (ii) non-individualised homeopathy/treat-
ment (n = 13); (iii) non-individualised homeopathy/
prophylaxis (n = 6). Data per trial include: nature of the
homeopathic intervention; study setting; the RCT’s
source of funding. Our definitions of ‘treatment’ and
‘prophylaxis’ were as previously described [1]. All RCTs
were identified as superiority trials, despite the fact that
in some cases the original authors applied the terms
‘equivalence trial’ or ‘non-inferiority trial’ post-hoc in
Results or in Discussion (A15, Faulstich 2006; A39,
Braun, 2011).
Extreme diversity characterised the studies as regards
species, medical condition, homeopathic medicine, and
funding source. In the 20 eligible studies, 6 different
species are represented: birds (n = 1); cattle (n = 11);
dogs (n = 1); horses (n = 1); pigs (n = 4); sheep (n = 2).
Twelve different conditions are represented. None of
the trials had a clearly unbiased funding source; we
identified overt vested interest in 10 of the 20 trials.
Table 2 includes: sample sizes; designated ‘main out-
come measure’; type of data (whether dichotomous or
continuous); study endpoint. Diversity was again appar-
ent, with large variation in sample sizes, main outcome,
and timing of the study endpoint.
Risk of bias
Table 3 shows our risk-of-bias judgments for each eli-
gible trial.
Many of the papers were written to such a poor stand-
ard that risk-of-bias assessments were sometimes challen-
ging. No trial had low risk of bias in all of the Cochrane
judgmental domains. Sixteen trials had high risk of bias in
one or more domains. Four trials had merely uncertain
risk of bias, and the uncertainty was evident in five do-
mains per study (A31, Reis 2006; A32, Reis 2008; A34,
Signoretti 2008; A36, Soto 2008). There was therefore no
trial that could be designated as reliable evidence.
Only five of the 20 trials had adequate randomisation
(domain I), and none of the trials had adequate alloca-
tion concealment (domain II) or personnel blinding
(domain IIIA). See also Fig. 1 (Risk-of-bias summary
graph).
Analysis of outcomes
Fifteen of the 20 trials had extractable data. Due to the
diversity of medical conditions, species, types of homeo-
pathic intervention, study designs and outcome mea-
sures, as well as the very unclear quality of the evidence,
it was not appropriate to carry out meta-analysis on
disease-specific intervention.
The direction of effect favoured homeopathy in 11 tri-
als (statistically significantly so in four cases) and
favoured control in four trials (statistically significantly
so in zero cases) – see Table 4, in which the inference
from the statistical findings is given by reference to the
numbered study designs in Methods: Direction of effect
of treatment/prophylaxis per trial.
Trials with uncertain risk of bias
In the absence of any trials with reliable evidence, our
main attention has been forced on to the data extracted
from three trials with uncertain risk of bias and without
overt vested interest (Table 4a): A32, Reis 2008 (modula-
tion of immune response to rabies vaccination in calves);
A34, Signoretti 2008 (cattle tick); A36, Soto 2008 (diar-
rhoea in piglets). All three trials were in the category
‘non-individualised/prophylaxis/‘[A + B] versus B’ design.
None of the three showed evidence of a difference be-
tween adjunctive homeopathy and active control alone,
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Table 1 Demographic details of 20 OTP-controlled RCTs in veterinary homeopathy
i: Individualised/Treatment


















Cattle A42 Lohr 2012 Active Oral electrolytes 3 complex preparations: Nux
vomica; Veratrum; Engystol





























Cattle A19 Silva 2008 Active Chemical dip 'Biotherapic' of Boophilus














Cattle A40 Lotfollahzadeh 2012 Active Anti-inflamatory
and antibiotic

















Lameness Horses A15 Faulstich 2006 Active Hyaluronic
acid
Complex of 14 homeopathically
prepared ingredients









Mastitis Cattle A16 Klocke 2010 Active Teat-sealer 8 remedies: Mercurius solubilis,
Lachesis mutus, Sulfur, Calcium
carbonicum, Calcium phosphoricum,























Table 1 Demographic details of 20 OTP-controlled RCTs in veterinary homeopathy (Continued)
Mastitis Cattle A20 Varshney 2005 Active Antibiotic Complex of 8 remedies: Healwell
VT-6 (Sintex International Limited,
Kalol, India), consisting of
Phytolacca, Calcarea fluorica,



















Pigs A39 Braun 2011 Active Antibiotic 2 complex preparations. Lachesis
compositum+ Traumeel















Sheep A17 Rocha 2006 (A + B) vs. B Anthelmintic
only









Cattle A34 Signoretti 2008 (A + B) vs. B Protein
supplement
only







Pigs A36 Soto 2008 (A + B) vs. B Sucrose
saline
only
Complex of 4 remedies: Echinacea
angustifolia, Avena sativa, Ignatia





Handling stress Cattle A31 Reis 2006 (A + B) vs. B Mineral salt
only
















Cattle A32 Reis 2008 (A + B) vs. B Mineral salt
only




























Table 1 Demographic details of 20 OTP-controlled RCTs in veterinary homeopathy (Continued)











*Note on homeopathic dilutions: The number refers to the number of successive serial dilutions to which the starting material has been subjected. The letter refers to the scale on which the dilution has been carried
out: the letter D denotes the decimal method of dilution (that is, one part of liquid is added to nine parts of purified water, ethanol, glycerol or lactose); the letter C indicates the centesimal method (one part added to
















Table 2 Sample sizes and outcomes for 20 OTP-controlled RCTs
i: Individualised/Treatment






























28 d N=No. of sows
treated
ii: Non-individualised/Treatment

























A42 Lohr 2013 53 56 109 46 54 100 8.3 Cure rate (Sum-
score (physical
condition))
Dichot. Higher Only 46 (Hom) and
54 (Cont) animals
regularly completed





based on 50 and
56 animals respectively.
Up to 4 d




Dichot. Higher No 12 d
A41 Catto 2013 72 36 108 72 36 108 0.0 Faecal egg count Contin. Lower Yes: Unclear sample
sizes – see Notes











A19 Silva 2008 9 9 18 ?9 ?9 ?18 Unclear Mean number of
engorged ticks
per annum




A40 Lotfollahzadeh 2012 52 23 75 50 15 65 13.3 Rectal
temperature















Table 2 Sample sizes and outcomes for 20 OTP-controlled RCTs (Continued)
A21 Zacharias 2008 7 7 14 ?7 ?7 ?14 Unclear Faecal egg count Contin. Lower No. Numbers for
analysis interpolated
from Figure 1A.
N not stated for
endpoint, but
assumed to be N= 7.






inspection of Fig 1
(1,300 approx.)
A15 Faulstich 2006 24 22 46 22 19 41 10.9 Treatment success
(overall effectiveness)




21 d Control really
active?
A16 Klocke 2010 32 36 68 32 36 68 0.0 Absence of clinical
mastitis infection
Dichot. Higher No: Data derived




A20 Varshney 2005 67 96 163 67 96 163 0.0 Quarter cure-rate
(non-fibrosed)




Up to 28 d N = quarters,
not animals
A39 Braun 2011 30 34 64 28 32 60 6.3 Cure rate
(MMA-sum score)
Dichot. Higher Up to 4 d (H)
or 3 d (C)
A13 Beceriklisoy 2008 30 8 38 30 8 38 0.0 Treatment 'success'
(recovery rate)
Dichot. Higher No Up to 20 d
A18 Sandoval 1998 200 200 400 200 200 400 0.0 Cumulative total
mortality
(1st quality broilers)






49 d N = 1st quality
broilers
A17 Rocha 2006 10 10 20 10 10 20 0.0 Proportion of animals
not requiring anti-
helminthic treatment
Dichot. Higher No: Data derived






























A34 Signoretti 2008 8 8 16 ?8 ?8 ?16 Unclear Faecal egg count
per gram
Contin. Lower No. But assumes
zero attrition rate.
Data from Table 3.
30 d
A36 Soto 2008 24 24 48 24 24 48 0.0 Number of
animal-days
with diarrhoea






















Table 2 Sample sizes and outcomes for 20 OTP-controlled RCTs (Continued)




60 d Hom plus mineral
salt vs. mineral
salt only
A32 Reis 2008 15 15 30 15 ?15 ?30 Unclear Rabies-neutralizing
antibody titer








A35 Sommer 1972 40 18 58 40 18 58 0.0 Number with
infertility disorders
Dichot. Lower No. Data from table 2 Not stated
A38 Williamson 1991 101 32 133 ?100 ?32 ?132 Unclear Number with
peripartum disorders
Dichot. Lower Yes: Unclear
tabulations
None















Table 3 Risk-of-bias assessments for 20 OTP-controlled RCTs
i: Individualised/Treatment






A12 Schütte N N N N Y N U 1 1 5 High No
ii: Non-individualised/Treatment






A42 Lohr Y U N Y Y N N 3 1 3 High No
A14 Coelho U U N U Y Y N 2 3 2 High No
A41 Catto U U N U U N U 0 5 2 High No
A19 Silva U U N U U N U 0 5 2 High No
A40 Lotfollahzadeh U U N Y U N Y 2 3 2 High No
A21 Zacharias U U N U U Y U 1 5 1 High No
A15 Faulstich Y U N Y Y Y Y 5 1 1 High No
A16 Klocke Y U N U Y Y Y 4 2 1 High No
A20 Varshney U U U U U Y N 1 5 1 High No
A39 Braun Y U N Y Y Y N 4 1 2 High No
A13 Beceriklisoy U U U U U Y N 1 5 1 High No
A18 Sandoval U U U U U N U 0 6 1 High No
A17 Rocha N N U U Y Y U 2 3 2 High No
iii: Non-individualised/Prophylaxis






A34 Signoretti U U U U U Y Y 2 5 0 Uncertain No
A36 Soto U U U U Y Y U 2 5 0 Uncertain No
A31 Reis 2006 U U U U U Y Y 2 5 0 Uncertain No
A32 Reis 2008 U U U U U Y Y 2 5 0 Uncertain No
A35 Sommer U U N U Y Y U 2 4 1 High No
A38 Williamson U U N U U N U 0 5 2 High No















and so in each case it was statistically inconclusive
whether homeopathy combined with conventional inter-
vention was more or was less effective than conventional
intervention alone – see Table 4a.
Trials at high risk of bias
Data could not be extracted from the single paper on
individualised treatment. Data were extractable from 10
of the 13 relevant RCTs of non-individualised treat-
ment; the direction of effect statistically significantly
favoured homeopathy in four of the ten cases – see
Table 4b. Two of these four yielded what appear to be
spuriously high mean OR values (A13, Bekeriklisoy
2008: OR = 95.86; A14, Coelho 2009: OR = 58.09). Of
the two RCTs of non-individualised prophylaxis (both
with untreated controls), data were extractable from
one (A35, Sommer 1972).
Discussion
This comprehensive systematic review of the peer-
reviewed literature has revealed no OTP-controlled RCT
of veterinary homeopathy that comprised reliable evi-
dence. Our main conclusions from this study are there-
fore restricted to the findings of three RCTs, whose
quality was unclear and whose methodological diversity
contraindicated meta-analysis. Each of these three trials
is in the category of non-individualised homeopathic
prophylaxis (A32, Reis 2008; A34, Signoretti 2008; A36,
Soto 2008), a prescribing approach that some homeo-
pathic practitioners might view as controversial [22].
Each of the three trials is also in the adjunctive category,
and manifested statistically inconclusive findings: this re-
sult undermines the suggestion that the ‘[A + B] versus
B’ study design can ‘generate only positive results’ [23].
For each of the above three trials, the uncertainty re-
garding risk of bias was so marked that their findings
must be viewed with extreme caution. Given the lack of
clarity in so many domains of assessment, this degree of
concern would still apply even if we had reflected more
leniently the fact that non-blinding of study personnel is
a typical feature of an OTP-controlled trial. The admis-
sible evidence in veterinary homeopathy for this study
design is therefore unable to provide any compelling in-
formation about modulation of immune response in
calves (A32, Reis 2008) or adjunctive prophylaxis of cat-
tle tick (A34, Signoretti 2008) or of diarrhoea in piglets
(A36, Soto 2008).
In assessing all the studies, we had reason on occa-
sions to question the veracity of the control group as an
‘active’ or effective intervention (e.g. mineral or protein
supplements, or naloxone in pseudopregnancy), and so
raised doubts about the ‘other than placebo’ nature of
some of the included trials. We were careful not to attri-
bute ‘equivalence’ to superiority trials that found no sta-
tistically significant difference between homeopathy and
active control [16, 19].
For OTP-controlled RCTs of non-individualised
homeopathic treatment, there is nothing that we can
reasonably conclude, given that each one of the trials
was judged to be at high risk of bias. Thus, the positive
inference we attributed to four trials in this category
cannot be regarded as admissible evidence; the spuri-
ously large treatment effect evidenced in two of the tri-
als reinforces those serious concerns. It remains
unknown whether non-individualised homeopathy is ef-
fective in the prophylaxis of fertility disorders in cattle.
Likewise, no conclusions can be made regarding indivi-
dualised homeopathic treatment, since the single trial
in this category was of very low quality and yielded no
extractable data for analysis.
Our most recent literature search, conducted during
the process of the current paper’s peer-review, revealed








Low risk of bias Unclear risk of bias High risk of bias
Fig. 1 Risk-of-bias summary graph. Illustrates, for each assessment domain, the proportion of RCTs with low, unclear and high risk of bias
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Table 4 Summary statistics for: (a) trials at uncertain risk of bias; (b) trials at high risk of bias
a) UNCERTAIN RISK OF BIAS
iii: Non-individualised/Prophylaxis




















Lower Cont. 0.17 [iii: b]
A36 Soto 2008 Diarrhoea (neonatal) Pigs Number of
animal-days
with diarrhoea
34/192 25/192 OR 0.70 [0.40,
1.22]
Lower Cont. 0.20 [iii: b]






Lower Hom. 0.64 [iii: b]










Higher Cont. 0.36 [iii: b]
b) HIGH RISK OF BIAS
i: Individualised/Treatment












A12 Schütte 1988 Mastitis, metritis
and agalactia
Pigs None useable X X X X X X X X
ii: Non-individualised/Treatment












A42 Lohr 2013 Diarrhoea
(neonatal)
Cattle Cure rate (Sum-score
[physical condition])
37/50 42/56 OR 0.95 [0.40,
2.28]
Higher Cont. 0.91 [iii: a]
A14 Coelho 2009 Diarrhoea
(neonatal)
Pigs Proportion of animals
without diarrhoea at
the end of treatment
35/35 5/9 OR 58.09 [2.73,
1234.82]
Higher Hom. 0.009 [i: a]
A41 Catto 2013 Ectoparasite
infestation
Cattle None useable X X X X X X X X
A19 Silva 2008 Ectoparasite
infestation
Cattle None useable X X X X X X X X
A40 Lotfollahzadeh 2012 Foot-and-mouth
disease






Lower Hom. <0.001 [i: a]
A21 Zacharias 2008 Gastrointestinal
nematodes






Lower Hom. 0.57 [iii: a]
A15 Faulstich 2006 Lameness Horses Treatment success
(overall effectiveness)
18/22 14/19 OR 1.61 [0.36,
7.12]















Table 4 Summary statistics for: (a) trials at uncertain risk of bias; (b) trials at high risk of bias (Continued)
A16 Klocke 2010 Mastitis Cattle Absence of clinical
mastitis infection
29/32 32/36 OR 1.21 [0.25,
5.86]
Higher Hom. 0.81 [iii: a]
A20 Varshney 2005 Mastitis Cattle Quarter cure-rate
(non-fibrosed)
58/67 57/96 OR 4.41 [1.96,
9.93]
Higher Hom. <0.001 [i: a]




20/28 21/32 OR 1.31 [0.44,
3.92]
Higher Hom. 0.63 [iii: a]
A13 Beceriklisoy 2008 Pseudopregnancy Dogs Treatment 'success'
(recovery rate)
30/30 3/8 OR 95.86 [4.32,
2126.07]
Higher Hom. 0.004 [i: a]
A18 Sandoval 1998 Salmonellosis Birds None useable X X X X X X X X
A17 Rocha 2006 Gastrointestinal
nematodes




7/10 5/10 OR 2.33 [0.37,
14.61]
Higher Hom. 0.37 [iii: b]
iii: Non-individualised/Prophylaxis












A35 Sommer 1972 Infertility Cattle Number with
infertility disorders
13/40 9/18 OR 2.08 [0.67,
6.47]
Lower Hom. 0.21 [iii: c]
A38 Williamson 1991 Infertility Cattle None useable X X X X X X X X
Hom. = homeopathy. Cont. = control. CI = confidence interval. sd = standard deviation. SMD = standardised mean difference. OR = odds ratio
Italic text indicates trials with a potential risk of bias due to funding source (see also Table 1)















only one further OTP-controlled trial that would poten-
tially have been eligible for inclusion [21]. Notwithstand-
ing normal concerns over the possibility that publication
bias may have limited the number of ‘negative’ studies
available, the present systematic review seems barely
compromised by selection bias due to absence of rele-
vant data.
Thus, the sum of the reliable peer-reviewed RCT evi-
dence in veterinary homeopathy (out of 18 placebo-
controlled and 20 OTP-controlled RCTs in total) com-
prises the two placebo-controlled trials that we previ-
ously identified [2, 3]. Evidence concerning the effective
use of homeopathy in animals remains indecisive.
Conclusions
Due to their extremely poor quality, OTP-controlled trials
are incapable of providing useful additional insight into
the effectiveness of homeopathic treatment or prophylaxis
in animals. To clarify the matter, new and substantially im-
proved OTP-controlled research in both individualised
and non-individualised veterinary homeopathy is strongly
indicated.
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